Search research articles
Contact Us
Filters
Showing results (221-230 of 311) with videos related to
Page
of 32
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
Dibromodulcitol plus bleomycin compared with bleomycin alone in head and neck cancer
B F Issell, G Borsos, J C D'Aoust, et al.
Cancer Research
|
April 1, 1982
Inhibition of PM-2 DNA degradation by a human serum protein
L Galvan, J E Evans, C H Huang, et al.
Medical and Pediatric Oncology
|
January 1, 1981
Phase II evaluation of mitomycin C (MMC) in children with refractory solid tumors using the single high-intermittent-dose schedule
M L Gutierrez, A Evans, T Rohrbaugh, et al.
Medical and Pediatric Oncology
|
January 1, 1978
The effects of prior exposure to bleomycin on the incidence of pulmonary toxicities in a group of patients with disseminated testicular carcinomas
S T Crooke, L H Einhorn, R L Comis, et al.
Molecular Pharmacology
|
September 1, 1987
Effect of auranofin and other gold complexes on the activity of phospholipase C
R M Snyder, C K Mirabelli, M A Clark, et al.
Molecular Pharmacology
|
August 1, 1987
SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4
S Mong, H L Wu, J Miller, et al.
Cancer Research
|
January 1, 1985
Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models
C K Mirabelli, R K Johnson, C M Sung, et al.
The Biochemical Journal
|
July 1, 1989
Solubilization of rat liver vasopressin receptors as a complex with a guanine-nucleotide-binding protein and phosphoinositide-specific phospholipase C
N Aiyar, C F Bennett, P Nambi, et al.
Biochemical Pharmacology
|
November 1, 1986
Evidence for tyrosine at the ligand binding center of beta-adrenergic receptors
R G Shorr, M D Minnich, L Gotlib, et al.
Biochemical and Biophysical Research Communications
|
February 28, 1979
Amino terminal amino acid sequence of macromomycin, a protein antitumor antibiotic
T H Sawyer, K Guetzow, M O Olson, et al.
Page
of 32
Search research articles
Search
Showing results (221-230 of 311) with videos related to
Sort By:
Page
of 32
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
Dibromodulcitol plus bleomycin compared with bleomycin alone in head and neck cancer
B F Issell, G Borsos, J C D'Aoust, et al.
Cancer Research
|
April 1, 1982
Inhibition of PM-2 DNA degradation by a human serum protein
L Galvan, J E Evans, C H Huang, et al.
Medical and Pediatric Oncology
|
January 1, 1981
Phase II evaluation of mitomycin C (MMC) in children with refractory solid tumors using the single high-intermittent-dose schedule
M L Gutierrez, A Evans, T Rohrbaugh, et al.
Medical and Pediatric Oncology
|
January 1, 1978
The effects of prior exposure to bleomycin on the incidence of pulmonary toxicities in a group of patients with disseminated testicular carcinomas
S T Crooke, L H Einhorn, R L Comis, et al.
Molecular Pharmacology
|
September 1, 1987
Effect of auranofin and other gold complexes on the activity of phospholipase C
R M Snyder, C K Mirabelli, M A Clark, et al.
Molecular Pharmacology
|
August 1, 1987
SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4
S Mong, H L Wu, J Miller, et al.
Cancer Research
|
January 1, 1985
Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models
C K Mirabelli, R K Johnson, C M Sung, et al.
The Biochemical Journal
|
July 1, 1989
Solubilization of rat liver vasopressin receptors as a complex with a guanine-nucleotide-binding protein and phosphoinositide-specific phospholipase C
N Aiyar, C F Bennett, P Nambi, et al.
Biochemical Pharmacology
|
November 1, 1986
Evidence for tyrosine at the ligand binding center of beta-adrenergic receptors
R G Shorr, M D Minnich, L Gotlib, et al.
Biochemical and Biophysical Research Communications
|
February 28, 1979
Amino terminal amino acid sequence of macromomycin, a protein antitumor antibiotic
T H Sawyer, K Guetzow, M O Olson, et al.
Page
of 32